145 related articles for article (PubMed ID: 37661117)
1. Severe and life-threatening onset of systemic lupus erythematosus.
Martins A; Pimenta S; Oliveira D; Martins F; Samões B; Costa L
Reumatol Clin (Engl Ed); 2023; 19(7):402-403. PubMed ID: 37661117
[TBL] [Abstract][Full Text] [Related]
2. Macrophage activation syndrome triggered by systemic lupus erythematosus flare: successful treatment with a combination of dexamethasone sodium phosphate, intravenous immunoglobulin, and cyclosporine: a case report.
Gouda W; Alsaqabi F; Moshrif A; Abbas AS; Abdel-Aziz TM; Islam MA
J Med Case Rep; 2021 Oct; 15(1):497. PubMed ID: 34620236
[TBL] [Abstract][Full Text] [Related]
3. Macrophage activation syndrome as the initial manifestation of severe juvenile onset systemic lupus erythematosus. Favorable response to cyclophosphamide.
Torres Jiménez A; Solís Vallejo E; Zeferino Cruz M; Céspedes Cruz A; Sánchez Jara B
Reumatol Clin; 2014; 10(5):331-5. PubMed ID: 24035795
[TBL] [Abstract][Full Text] [Related]
4. Macrophage activation syndrome at the onset of glucocorticoid-resistant systemic lupus erythematosus: a case report.
Tulbă D; Balea M; Băicuş C
Rom J Intern Med; 2018 Mar; 56(1):67-70. PubMed ID: 28918421
[TBL] [Abstract][Full Text] [Related]
5. Systemic lupus erythematosus complicated with macrophage activation syndrome mimicking COVID-19 multisystemic inflammatory syndrome in children.
Domínguez-Rojas J; Atamari-Anahui N; Chonlon-Murillo K; Tello M; Coronado-Muñoz Á
Bol Med Hosp Infant Mex; 2021; 78(6):642-646. PubMed ID: 34934208
[TBL] [Abstract][Full Text] [Related]
6. Arthritis and use of hydroxychloroquine associated with a decreased risk of macrophage activation syndrome among adult patients hospitalized with systemic lupus erythematosus.
Cohen EM; D'Silva K; Kreps D; Son MB; Costenbader KH
Lupus; 2018 Jun; 27(7):1065-1071. PubMed ID: 29451069
[TBL] [Abstract][Full Text] [Related]
7. [Systemic lupus erythematosus associated macrophage activation syndrome with neuropsychiatric symptoms: A report of 2 cases].
Luo ZJ; Wu JJ; Song Y; Mei CL; DU R
Beijing Da Xue Xue Bao Yi Xue Ban; 2023 Dec; 55(6):1111-1117. PubMed ID: 38101797
[TBL] [Abstract][Full Text] [Related]
8. Macrophage activation syndrome in children with systemic juvenile idiopathic arthritis and systemic lupus erythematosus.
Aytaç S; Batu ED; Ünal Ş; Bilginer Y; Çetin M; Tuncer M; Gümrük F; Özen S
Rheumatol Int; 2016 Oct; 36(10):1421-9. PubMed ID: 27510530
[TBL] [Abstract][Full Text] [Related]
9. Macrophage activation syndrome as initial presentation of systemic lupus erythematosus.
Yeap ST; Sheen JM; Kuo HC; Hwang KP; Yang KD; Yu HR
Pediatr Neonatol; 2008 Apr; 49(2):39-42. PubMed ID: 18947015
[TBL] [Abstract][Full Text] [Related]
10. Recurrent macrophage activation syndrome as the initial manifestation of paediatric systemic lupus erythematosus.
Dey S; Roongta R; Mondal S; Haldar S; Sircar G; Ghosh B; Ghosh A
Lupus; 2022 Aug; 31(9):1132-1137. PubMed ID: 35713230
[No Abstract] [Full Text] [Related]
11. Macrophage activation syndrome in systemic lupus erythematosus: a multicenter, case-control study in China.
Liu AC; Yang Y; Li MT; Jia Y; Chen S; Ye S; Zeng XZ; Wang Z; Zhao JX; Liu XY; Zhu J; Zhao Y; Zeng XF; Li ZG
Clin Rheumatol; 2018 Jan; 37(1):93-100. PubMed ID: 28409239
[TBL] [Abstract][Full Text] [Related]
12. Macrophage activation syndrome associated with systemic lupus erythematosus treated successfully with the combination of steroid pulse, immunoglobulin and tacrolimus.
Aoyama-Maeda N; Horino T; Ichii O; Terada Y
Rom J Intern Med; 2018 Jun; 56(2):117-121. PubMed ID: 29099692
[TBL] [Abstract][Full Text] [Related]
13. Novel use of rituximab in macrophage activation syndrome secondary to systemic lupus erythematosus.
Junga Z; Stitt R; Tracy C; Keith M
BMJ Case Rep; 2017 Aug; 2017():. PubMed ID: 28827301
[TBL] [Abstract][Full Text] [Related]
14. The dynamism of cutaneous lupus erythematosus: mild discoid lupus erythematosus evolving into SLE with SCLE and treatment-resistant lupus panniculitis.
Wozniacka A; Salamon M; Lesiak A; McCauliffe DP; Sysa-Jedrzejowska A
Clin Rheumatol; 2007 Jul; 26(7):1176-9. PubMed ID: 16645776
[TBL] [Abstract][Full Text] [Related]
15. [Systemic lupus erythematosus presenting as Stevens-Johnson syndrome].
Bellakhal S; Ben Kaab B; Teyeb Z; Souissi A; Derbel F; Douggui MH
Pathol Biol (Paris); 2015 Sep; 63(4-5):222-3. PubMed ID: 26088436
[TBL] [Abstract][Full Text] [Related]
16. Hemophagocytic syndrome as the initial manifestation of systemic lupus erythematosus.
Egües Dubuc CA; Uriarte Ecenarro M; Meneses Villalba C; Aldasoro Cáceres V; Hernando Rubio I; Belzunegui Otano J
Reumatol Clin; 2014; 10(5):321-4. PubMed ID: 24316336
[TBL] [Abstract][Full Text] [Related]
17. Macrophage activation syndrome in a patient with systemic lupus erythematosus undergoing cyclophosphamide treatment: a case report.
Fioravante da Silveira L; Zago A; Zanchet D; Chemello D
Reumatismo; 2023 Jul; 75(2):. PubMed ID: 37462126
[TBL] [Abstract][Full Text] [Related]
18. Erythematosus plaques with macrophage infiltration as an initial manifestation of macrophage activation syndrome in a patient with systemic lupus erythematosus.
Tochihara M; Kasai M; Katsumata Y; Sato E; Ishiguro N; Kazama H; Sugimoto N; Ichida H; Kawaguchi Y; Yamanaka H
Mod Rheumatol; 2016 Nov; 26(6):956-957. PubMed ID: 25036234
[TBL] [Abstract][Full Text] [Related]
19. Systemic lupus erythematosus associated with development of macrophage activation syndrome and disseminated aspergillosis.
Phoophiboon V; Brown P; Burns KEA
Can J Anaesth; 2023 Jul; 70(7):1255-1260. PubMed ID: 37349668
[TBL] [Abstract][Full Text] [Related]
20. Macrophage activation syndrome as an initial presentation of systemic lupus erythematosus with sensorineural hearing loss in a young male patient.
Tan CL; Yahaya MH; Ahmad NS; Lim CH
BMJ Case Rep; 2020 Mar; 13(3):. PubMed ID: 32169986
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
